The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 20 May 2003
doi: 10.1242/jcs.00494
Research Article
Specific inhibition of pathological prion protein accumulation by small interfering RNAs
Nathalie Daude,
Mathieu Marella,
and
Joëlle Chabry*
* Author for correspondence (e-mail: chabry{at}ipmc.cnrs.fr)
Development of transmissible spongiform encephalopathies (TSEs) pathogenesis requires the presence of both the normal host prion protein (PrP-sen) and the abnormal pathological proteinase-K resistant isoform (PrP-res). PrP-res forms highly insoluble aggregates, with self-perpetuating properties, by binding and converting PrP-sen molecules into a likeness of themselves. In the present report, we show that small interfering RNA (siRNA) duplexes trigger specific Prnp gene silencing in scrapie-infected neuroblastoma cells. A non-passaged, scrapie-infected culture transfected with siRNA duplexes is depleted of PrP-sen and rapidly loses its PrP-res content. The use of different murine-adapted scrapie strains and host cells did not influence the siRNA-induced gene silencing efficiency. More than 80% of transfected cells were positive for the presence of fluorescein-labeled siRNA duplexes. No cytotoxicity associated with the use of siRNA was observed during the time course of these experiments. Despite a transient abrogation of PrP-res accumulation, our results suggest that the use of siRNA may provide a new and promising therapeutic approach against prion diseases.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. D. White, M. Farmer, I. Mirabile, S. Brandner, J. Collinge, and G. R. Mallucci
Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease
PNAS,
July 22, 2008;
105(29):
10238 - 10243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-P. Courageot, N. Daude, R. Nonno, S. Paquet, M. A. Di Bari, A. Le Dur, J. Chapuis, A. F. Hill, U. Agrimi, H. Laude, et al.
A cell line infectible by prion strains from different species
J. Gen. Virol.,
January 1, 2008;
89(1):
341 - 347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Paquet, N. Daude, M.-P. Courageot, J. Chapuis, H. Laude, and D. Vilette
PrPc Does Not Mediate Internalization of PrPSc but Is Required at an Early Stage for De Novo Prion Infection of Rov Cells
J. Virol.,
October 1, 2007;
81(19):
10786 - 10791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Dirikoc, S. A. Priola, M. Marella, N. Zsurger, and J. Chabry
Nonpsychoactive Cannabidiol Prevents Prion Accumulation and Protects Neurons against Prion Toxicity
J. Neurosci.,
September 5, 2007;
27(36):
9537 - 9544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kuwata, N. Nishida, T. Matsumoto, Y. O. Kamatari, J. Hosokawa-Muto, K. Kodama, H. K. Nakamura, K. Kimura, M. Kawasaki, Y. Takakura, et al.
Hot spots in prion protein for pathogenic conversion
PNAS,
July 17, 2007;
104(29):
11921 - 11926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. T. Parkin, N. T. Watt, I. Hussain, E. A. Eckman, C. B. Eckman, J. C. Manson, H. N. Baybutt, A. J. Turner, and N. M. Hooper
Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein
PNAS,
June 26, 2007;
104(26):
11062 - 11067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R Trevitt and J. Collinge
A systematic review of prion therapeutics in experimental models
Brain,
September 1, 2006;
129(9):
2241 - 2265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Weber, F. M. de Queiroz, B. R. Downie, A. Suckow, W. Stuhmer, and L. A. Pardo
Silencing the Activity and Proliferative Properties of the Human EagI Potassium Channel by RNA Interference
J. Biol. Chem.,
May 12, 2006;
281(19):
13030 - 13037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Golding, C. R. Long, M. A. Carmell, G. J. Hannon, and M. E. Westhusin
Suppression of prion protein in livestock by RNA interference
PNAS,
April 4, 2006;
103(14):
5285 - 5290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Safar, K. Kellings, A. Serban, D. Groth, J. E. Cleaver, S. B. Prusiner, and D. Riesner
Search for a Prion-Specific Nucleic Acid
J. Virol.,
August 15, 2005;
79(16):
10796 - 10806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Crozet, Y.-L. Lin, C. Mettling, C. Mourton-Gilles, P. Corbeau, S. Lehmann, and V. Perrier
Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations
J. Cell Sci.,
November 1, 2004;
117(23):
5591 - 5597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Paquet, E. Sabuncu, J.-L. Delaunay, H. Laude, and D. Vilette
Prion Infection of Epithelial Rov Cells Is a Polarized Event
J. Virol.,
July 1, 2004;
78(13):
7148 - 7152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Luhr, E. K. Nordstrom, P. Low, H.-G. Ljunggren, A. Taraboulos, and K. Kristensson
Scrapie Protein Degradation by Cysteine Proteases in CD11c+ Dendritic Cells and GT1-1 Neuronal Cells
J. Virol.,
May 1, 2004;
78(9):
4776 - 4782.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2003